Unveiling a New Cholinesterase Inhibitor Iridoid From Verbascum uschakense (Murb.) Hub.‐Mor.: In Vitro and In Silico Evaluation
Chemical Biology & Drug Design · 2025
DOI: 10.1111/cbdd.70178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Rabia Sena Mındız und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, Faculty of Pharmacy, Hacettepe University, Ankara, Türkiye. Hauptthemen laut MEDLINE: Cholinesterase Inhibitors, Verbascum, Iridoids. Die Arbeit nennt 63 Literaturangaben. Gefördert von: Hacettepe University, Hacettepe Üniversitesi.
Abstract (Originalsprache)
Verbascum L., a member of the Scrophulariaceae family, is the second‐largest genus in Turkish flora. It is represented by over 250 species, many of which have been used as folk medicine. This study aims to determine the cholinesterase inhibitory potential of secondary metabolites of Verbascum uschakense (Murb.) Hub.‐Mor, an endemic species to Türkiye that has not been studied phytochemically before. Gluroside, an iridoid glucoside, was isolated from V. uschakense through acetylcholinesterase (AChE) inhibitory activity‐guided fractionation alongside four other iridoid glucosides: ajugol, harpagide, aucubin, and catalpol. Additionally, three phenylethanoid glycosides—verbascoside, martinoside, and forsythoside B—were isolated from the antioxidant fractions evaluated using DPPH radical scavenging activity. Gluroside emerged as the most active compound against butyrylcholinesterase (BChE) with an IC 50 of 2.5 ± 0.02 μg/mL, exhibiting selectivity over AChE (37.69% inhibition at 200 μg/mL). Molecular modeling predicted strong electrostatic interactions between the glucosides and the catalytic residues of BChE. This is the first report of the isolation of gluroside from a Verbascum species and its cholinesterase inhibitory activity, underpinning the importance of V. uschakense and its secondary metabolites as a new class of cholinesterase inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacognosy, Faculty of Pharmacy, Hacettepe University, Ankara, Türkiye.
- Department of Pharmacognosy, Faculty of Pharmacy, Bezmialem Vakıf University, İstanbul, Türkiye.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Türkiye.
- Department of Biology, Faculty of Science, Gazi University, Ankara, Türkiye.
ORCID-Profile: Rabia Sena Mındız, Gülaçtı Topçu, Didem Şöhretoğlu, Suat Sari, Mehmet Ufuk Özbek, Çiğdem Kahraman
Förderung
- Hacettepe University
- Hacettepe Üniversitesi
Zitieren
APA
Mındız, R. S., Topçu, G., Şöhretoğlu, D., Sari, S., Özbek, M. U., & Kahraman, Ç. (2025). Unveiling a New Cholinesterase Inhibitor Iridoid From Verbascum uschakense (Murb.) Hub.‐Mor.: In Vitro and In Silico Evaluation. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70178
Vancouver
Mındız RS, Topçu G, Şöhretoğlu D, Sari S, Özbek MU, Kahraman Ç. Unveiling a New Cholinesterase Inhibitor Iridoid From Verbascum uschakense (Murb.) Hub.‐Mor.: In Vitro and In Silico Evaluation. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70178
BibTeX
@article{Mndz2025,
author = {Mındız, Rabia Sena and Topçu, Gülaçtı and Şöhretoğlu, Didem and Sari, Suat and Özbek, Mehmet Ufuk and Kahraman, Çiğdem},
title = {Unveiling a New Cholinesterase Inhibitor Iridoid From Verbascum uschakense (Murb.) Hub.‐Mor.: In Vitro and In Silico Evaluation},
journal = {Chemical Biology & Drug Design},
year = {2025},
doi = {10.1111/cbdd.70178}
}
EUVIMED